Recombinant Protein Market Report 2023 (Global Edition)

Global Recombinant Protein Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Recombinant Protein Industry growth. Recombinant Protein market has been segmented with the help of its Product, Application End-user, and others. Recombinant Protein market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.

Report scope is customizable as we have a huge database of Recombinant Protein industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.

By type, the antibodies segment dominates the global recombinant protein market anticipated to grow with the highest revenue share. This is attributed to rising of chronic diseases like diabetes, which is increasing the demand for recombinant antibodies.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Recombinant Protein Industry. Request a Free Sample PDF!

By application, the therapeutics segment dominated the global market with the maximum share. This is attributed to the rising demand for protein-based treatment, protein treatment offers extremely effective treatments for diseases like infectious disorders, diabetes, cancer, and others.

The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Recombinant Protein market report 2023 Edition by contacting our team.

Recombinant Protein End-user Segment Analysis

By end users, the biotechnology and pharmaceutical companies segment dominates the global recombinant protein market with the highest revenue share. Increasing fund raising activities by major market players for the development of drugs drives the demand for the target market.

• Pharma & Biotechnology Companies
• Academic & Research Institutes
• Diagnostic Laboratories
• Others

Recombinant Protein Host Cell Segment Analysis

• Mammalian Systems
• Insect Cells
• Yeast & Fungi
• Bacterial Cells
• Others

North America dominated the global recombinant protein market and accounted for the maximum share. This is attributed due to the availability of healthcare infrastructure, the presence of major market players, and rising research investment. Furthermore, the Asia Pacific region is expected to be the fastest-growing segment over the forecast period. An increase in the prevalence of major chronic diseases in developing countries such as India and China drive the growth of the target market.

Region-wise, the market is analyzed across: (In case you wish to acquire a specific region or any country data then please contact us)

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!

News:
January 2022,
Thermo Fisher Scientific Acquired PeproTech.
Thermo fisher scientific acquired PeproTech which is a leader in recombinant proteins and a provider of bioscience reagents known as recombinant proteins, including cytokines and growth factors.

December 2020,
Bio-Techne Corporation (US) has collaborated with Elpiscience. 
Bio-Techne Corporation (US) has collaborated with Elpiscience. As part of this collaboration, Elpiscience would have access to Bio-large Techne's antibody product line for use in the development of preclinical, clinical, and commercial biopharmaceuticals with the goal of developing anticancer therapies.

Top Companies Market Share in Recombinant Protein Industry: (In no particular order of Rank)

• Boehringer Ingelheim
• Bristol Myers Squibb
• Eli Liily
• GlaxoSmithKline
• Merck
• Regeneron Pharmaceuticals
• Roche
• Shire Pharmaceuticals
• Bayer
• Amgen
• Confidential Data
• Access The Paid Version
• Data Hidden

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables..